ADAP
Marshall Wace’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-529,123
| Closed | -$286K | – | 2437 |
|
|
2024
Q4 | $286K | Buy |
529,123
+6,515
| +1% | +$3.52K | ﹤0.01% | 2097 |
|
|
2024
Q3 | $496K | Buy |
522,608
+377,728
| +261% | +$359K | ﹤0.01% | 1775 |
|
|
2024
Q2 | $141K | Sell |
144,880
-109,133
| -43% | -$106K | ﹤0.01% | 2147 |
|
|
2024
Q1 | $401K | Buy |
+254,013
| New | +$401K | ﹤0.01% | 1770 |
|
|
2023
Q3 | – | Sell |
-272,681
| Closed | -$254K | – | 1793 |
|
|
2023
Q2 | $254K | Buy |
+272,681
| New | +$254K | ﹤0.01% | 1759 |
|
|
2023
Q1 | – | Sell |
-89,171
| Closed | -$130K | – | 2077 |
|
|
2022
Q4 | $130K | Buy |
+89,171
| New | +$130K | ﹤0.01% | 2169 |
|
|
2022
Q1 | – | Sell |
-567,796
| Closed | -$2.13M | – | 2541 |
|
|
2021
Q4 | $2.13M | Sell |
567,796
-986,004
| -63% | -$3.7M | ﹤0.01% | 1595 |
|
|
2021
Q3 | $8.03M | Buy |
+1,553,800
| New | +$8.03M | 0.03% | 613 |
|
|
2020
Q3 | – | Sell |
-376,340
| Closed | -$3.77M | – | 1497 |
|
|
2020
Q2 | $3.77M | Buy |
+376,340
| New | +$3.77M | 0.03% | 548 |
|
|
2020
Q1 | – | Sell |
-29,102
| Closed | -$35K | – | 1577 |
|
|
2019
Q4 | $35K | Sell |
29,102
-50,146
| -63% | -$60.3K | ﹤0.01% | 1522 |
|
|
2019
Q3 | $120K | Buy |
+79,248
| New | +$120K | ﹤0.01% | 1326 |
|
|
2019
Q1 | – | Sell |
-130,050
| Closed | -$748K | – | 1667 |
|
|
2018
Q4 | $748K | Buy |
+130,050
| New | +$748K | 0.01% | 986 |
|
|
2016
Q1 | – | Sell |
-140,983
| Closed | -$1.7M | – | 1009 |
|
|
2015
Q4 | $1.7M | Buy |
+140,983
| New | +$1.7M | 0.02% | 596 |
|